¿¬¼ö°­ÁÂ
2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-03-09

2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-03-09
±³À°ÀÏÀÚ : 2024-03-09
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  

À̸ÞÀÏ : office@thyroid.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í " 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 08:30~08:50 Clinical risk factors and risk stratification À̵¿±Ù(µ¿¾ÆÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 08:50~09:10 Imaging- based diagnosis and risk stratification À̹ΰæ(°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 09:10~09:30 Interventional management of recurrent thyroid cancer ¹éÁ¤È¯(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 09:30~09:40 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 09:40~10:00 Recent results from the MAeSTro Study compared to prospective cohort studies in other countries ¹®ÀçÈÆ(¼­¿ïÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 10:00~10:20 Protocols of guidelines and prospective studies on AS of low risk PTC ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 10:20~10:40 Standardized imaging for thyroid ultrasound in AS of low risk thyroid cancer: KSThR consensus statement ÀÌÁö¿¹(¼­¿ïÀÇ´ë ¿µ»óÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 10:40~10:50 Discussion ( )

ÈÞ½Ä 03¿ù 09ÀÏ 201È£ 10:50~11:10 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 11:10~12:10 Genome editing and medicine ±èÇü¹ü(¿¬¼¼ÀÇ´ë ¾à¸®Çб³½Ç)

±âŸ 03¿ù 09ÀÏ 201È£ 12:10~12:30 ÃÑȸ ( )

½Ä»ç 03¿ù 09ÀÏ 201È£ 12:30~13:20 Lunch ( )

Åä·Ð 03¿ù 09ÀÏ 201È£ 13:20~14:20 ÆгÎÅäÀÇ ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 14:20~15:00 How to minimize the complications of the thyroid surgery ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú)

ÈÞ½Ä 03¿ù 09ÀÏ 201È£ 15:00~15:20 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 15:20~15:50 Organoids in thyroid gland À¯¹ÎÈñ(¾ÈÀü¼ºÆò°¡¿¬±¸¼Ò)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 15:50~16:20 Epigenomic analysis in thyroid cancer ±è¶ô±Õ(¿¬¼¼ÀÇ´ë ÀÇ»ý¸í°øÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 16:20~16:30 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 16:30~16:55 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼±¾Ï Áø·á±Ç°í¾È ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 16:55~17:20 ÆгÎÅäÀÇ ÀÓµ¿ÁØ ³ªµ¿±Ô ±èÁ¤ÇÑ ±¸º»¼® Á¤Âù±Ç ÀÌ»ó¿ì(°¡Å縯ÀÇ´ë ³»°ú °­¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú ¼º±Õ°üÀÇ´ë ¿Ü°ú Ãæ³²ÀÇ´ë À̺ñÀÎÈÄ°ú °¡Å縯ÀÇ´ë º´¸®°ú °æºÏÀÇ´ë ÇÙÀÇÇаú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 17:20~17:30 ÀúÀ§Ç豺 °©»ó¼±¾ÏÀÇ Ä¡·á ¹æħ¿¡ ´ëÇÑ KTA ¼³¹®°á°ú ±è¹ÎÁÖ(¼­¿ïÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 17:30~17:40 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 17:40~17:50 °©»ó¼±±â´ÉÇ×ÁøÁõÀÇ ¹æ»ç¼º¿ä¿ÀµåÄ¡·á ±Ç°í¾È ±è°æÁø(°í·ÁÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 17:50~18:00 Discussion ( )

±âŸ 03¿ù 09ÀÏ 201È£ 18:00~18:10 ½Ã»ó½Ä ¹× Closing Remark ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:30~08:40 [±¸¿¬¹ßÇ¥] Ultrasound-Guided Thrombin Injection for the treatment of choice for iatrogenic thyroid pseudoaneurysm "ÇÔÅÂÇõ (¼­¿ï´ëÇб³º´¿ø ¿µ»óÀÇÇаú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:40~08:50 [±¸¿¬¹ßÇ¥] Cost-effectiveness of diagnosis by ultrasound for asymptomatic thyroid cancer in South Korea "Á¤È£Áß (°­³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:50~09:00 [±¸¿¬¹ßÇ¥] Intraoperative Neuromonitoring During Thyroidectomy Does Not Decrease Vocal Cord Palsy Risk, but Cumulative Experience May "¿À¹®¿µ (¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:00~09:10 [±¸¿¬¹ßÇ¥] Association between M2 macrophage infiltrations and radioactive iodine sensitivity in thyroid cancer "ÀÌÀÚ°æ (ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:10~09:20 [±¸¿¬¹ßÇ¥] Continuous intraoperative nerve monitoring in thyroidectomy using automatic periodic stimulation: preliminary case series "¹èÁØÇü (ºÐ´ç¼­¿ï´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:20~09:30 [±¸¿¬¹ßÇ¥] ´ëÇѵΰæºÎ¿Ü°úÇÐȸ °©»ó¼±¾Ï °ËÁø ¹× Ä¡·á µ¿Çâ ´ëȸ¿ø Á¶»ç º¸°í "±èÁö¿ø (ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:40~10:00 °©»ó¼± ¼ö¼úÀÇ Á¾·ù¿Í ÀÔ¿øȯÀÚ ÄɾîÀÇ ÁÖÀÇÁ¡ ÇãÁØ(¿¬¼¼ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 10:00~10:20 °©»ó¼± ¾àÁ¦ÀÇ Ã³¹æ ¹× º¹¿ë ¿ä·É ¼ÛÀÇ¿¬(°í·ÁÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 10:20~10:40 ¹æ»ç¼º ¿ä¿Àµå Ä¡·á ÈÄ È¯ÀÚ ÄÉ¾î ¹Ú¼ÒÇö(±¹¸³¾Ï¼¾ÅÍ ÇÙÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 204,5È£ 10:40~10:50 Discussion ( )

ÈÞ½Ä 03¿ù 09ÀÏ 204,5È£ 10:50~11:10 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 15:20~15:40 Pros for T3 + T4 combination À̽ÃÈÆ(°¡ÃµÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 15:40~16:00 Cons for T3 + T4 combination ±èº¸Çö(ºÎ»êÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 16:00~16:20 A Comprehensive overveiw of recent guidelines ±è´ÙÇÔ(¿¬¼¼ÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 204,5È£ 16:20~16:30 Discussion ( )

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,163 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇѳ»ºÐºñÇÐȸ SICEM 2024(1ÀÏÂ÷) : 2024-04-11

±³À°ÀÏÀÚ : 2024-04-11 ±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï ±³À°ÁÖÁ¦ : SICEM 2024(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ ´ã´çÀÚ : ¹Ú¼öºó ¿¬¶ôó : 02-2038-0

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,062 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,211 , ´ñ±Û¼ö : 0

[±¤ÁÖ] ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd day : 2024-04-26

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁß ÄÁº¥¼Ç ¼¾ÅÍ ÄÁº£¼Ç Ȧ ¿Ü 8°÷ ±³À°ÁÖÁ¦ : ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦42Â÷ Ãá°èÇмú´ëȸ_2nd dayÁÖÃÖ±â°ü : ´ëÇѽŰæ¿Ü°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 906 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Surgeon : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : °­³²¼¼ºê¶õ½ºº´¿ø ´ë°­´ç ±³À°ÁÖÁ¦ : Á¦21ȸ ¿¬¼¼ÀÇ´ë ôÃ߽Ű濬±¸¼Ò ½ÉÆ÷Áö¾ö: Symposium for Young Spine Sur

Ãßõ¼ö : 0 , Á¶È¸¼ö : 1,126 , ´ñ±Û¼ö : 0